Publication Detail
The publication detail shows the title, authors (with indicators showing other profiled authors), information on the publishing organization, abstract and a link to the article in PubMed. This abstract is what is used to create the fingerprint of the publication. If any grants are referenced by the publication, they will be listed here as well.
Expression of angiogenesis-related molecules in plexiform lesions in severe pulmonary hypertension: evidence for a process of disordered angiogenesis.
R M Tuder; M Chacon; L Alger; J Wang; L Taraseviciene-Stewart; Y Kasahara; C D Cool; A E Bishop; M Geraci; G L Semenza; et al. (Profiled Authors: Gregg Semenza; Rubin Tuder; Jian Wang)
Department of Pathology, Division of Pulmonary Sciences and Critical Care Medicine, Pulmonary Hypertension Center, University of Colorado Health Sciences Center, Colorado, USA.
The Journal of pathology 2001;195(3):367-74.
Pulmonary arteries of patients with severe pulmonary hypertension (SPH) presenting in an idiopathic form (primary PH-PPH) or associated with congenital heart malformations or collagen vascular diseases show plexiform lesions. It is postulated that in lungs with SPH, endothelial cells in plexiform lesions express genes encoding for proteins involved in angiogenesis, in particular, vascular endothelial growth factor (VEGF) and those involved in VEGF receptor-2 (VEGFR-2) signalling. On immunohistochemistry and in situ hybridization, endothelial cells in the plexiform lesions expressed VEGF mRNA and protein and overexpressed the mRNA and protein of VEGFR-2, and the transcription factor subunits HIF-1alpha and HIF-1beta of hypoxia inducible factor, which are responsible for the hypoxia-dependent induction of VEGF. When compared with normal lungs, SPH lungs showed decreased expression of the kinases PI3 kinase and src, which, together with Akt, relay the signal transduction downstream of VEGFR-2. Because markers of angiogenesis are expressed in plexiform lesions in SPH, it is proposed that these lesions may form by a process of disordered angiogenesis.
Scientific Context
This section shows information related to the publication - computed using the fingerprint of the publication - including related publications, related experts and related grants with fingerprints representing significant amounts of overlap between their fingerprint and this publication. The red dots indicate whether those experts or terms appear within the publication, thereby showing potential and actual connections.
Related Publications
-
1.
1999C D Cool; J S Stewart; P Werahera; G J Miller; R L Williams; N F Voelkel; R M Tuder
The American journal of pathology 1999;155(2):411-9. -
2.
2002Norbert F Voelkel; Carlyne Cool; Laima Taraceviene-Stewart; Mark W Geraci; Michael Yeager; Todd Bull; Michael Kasper; Rubin M Tuder
Critical care medicine 2002;30(5 Suppl):S251-6. -
3.
2000H Ozaki; M S Seo; K Ozaki; H Yamada; E Yamada; N Okamoto; F Hofmann; J M Wood; P A Campochiaro
The American journal of pathology 2000;156(2):697-707.
Related Topics
Appears in this Publication
-
Vascular Endothelial Growth ...
-
-
Vascular Endothelial Growth ...
-
alpha Subunit Hypoxia-Induci...
-
-
Vascular Endothelial Growth ...
-
-
-
Receptor Protein-Tyrosine Ki...
-
-
-
Neovascularization, Patholog...
-
Vascular Endothelial Growth ...
-
-
-
-
-
-
Intercellular Signaling Pept...
-
Related Experts
Author of this Publication
-
Internal ExpertsPublications
-
298









-
242









-
35









-
307









-
680









-
26









